← Back to Search

Goal Setting Intervention for Chronic Knee Pain (mGAME Trial)

N/A
Recruiting
Led By Paul Werth, PhD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 months
Awards & highlights

mGAME Trial Summary

This trial tests how well an intervention helps patients set goals to improve their medical treatment.

Who is the study for?
This trial is for adults over 21 who are new or existing patients scheduled to see an orthopaedic surgeon for knee issues. It's not open to those unable to consent, non-English speakers, or anyone less than a year out from prior spine, hip, or knee surgery.Check my eligibility
What is being tested?
The study tests a goal development intervention that helps patients set and track specific and measurable goals for their knee treatment. The effectiveness of this personalized approach will be evaluated.See study design
What are the potential side effects?
Since the interventions involve setting and tracking treatment goals rather than medical procedures or drugs, traditional side effects are not applicable. However, there may be psychological impacts related to goal attainment success.

mGAME Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To evaluate the effectiveness of the goal development intervention using the Goal Attainment Outcome Measure
Secondary outcome measures
To assess the intervention's ability to improve shared decision making using the collaboRATE measure

mGAME Trial Design

3Treatment groups
Active Control
Group I: Goal Development and Tracking InterventionActive Control2 Interventions
Group II: Goal Attainment InterventionActive Control1 Intervention
Group III: Goal Development InterventionActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Dartmouth-Hitchcock Medical CenterLead Sponsor
524 Previous Clinical Trials
2,540,529 Total Patients Enrolled
1 Trials studying Knee Injuries
30 Patients Enrolled for Knee Injuries
Medacta USAIndustry Sponsor
16 Previous Clinical Trials
1,820 Total Patients Enrolled
Paul Werth, PhDPrincipal InvestigatorDartmouth-Hitchcock Medical Center

Media Library

Goal Attainment Clinical Trial Eligibility Overview. Trial Name: NCT05652270 — N/A
Knee Injuries Research Study Groups: Goal Development and Tracking Intervention, Goal Attainment Intervention, Goal Development Intervention
Knee Injuries Clinical Trial 2023: Goal Attainment Highlights & Side Effects. Trial Name: NCT05652270 — N/A
Goal Attainment 2023 Treatment Timeline for Medical Study. Trial Name: NCT05652270 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still capacity to enroll new participants in this experiment?

"Per the information available on clinicaltrials.gov, this experiment is actively inviting participants to join since April 21st 2023 and was last updated on May 10th of the same year."

Answered by AI

How many participants can this research accommodate?

"Affirmative, the details on clinicaltrials.gov demonstrate that recruitment for this investigation is ongoing. The trial was first publicized on April 21st 2023 and recently revised on May 10th 2023. A total of 230 individuals will be admitted from 1 research location."

Answered by AI
~130 spots leftby Apr 2025